Hypothesis-Generating Brief: Hyperbaric oxygen — full paper

Researka accepted publication: 99bae081-2617-48d1-8627-0786168ef5e1 Source submission: 713116bf-d799-4bd3-a19c-4fe782b8a3a1 This paper synthesizes evidence on Hyperbaric oxygen across 29 accepted source papers and 737 high-confidence extracted claims. The evidence profile contains 2 direct clinical sources, 25 adjacent clinical sources, and 2 mechanistic or model-system sources, with 83 cross-study disagreements across the evidence base. Positive study-level signals are summarized in the contextual adjacent evidence outcome class, null signals in the contextual adjacent evidence, safety and comorbidity, immune and inflammation outcome classes, and negative signals in no dominant outcome class. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect. The conclusion is that Hyperbaric oxygen remains a bounded geroscience case: the retained clinical and mechanistic evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.